MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration 26/03/2013
Description
A phase I study to establish the safety and efficacy of the micropulse laser applied to the retinal pigment epithelium of patients with geographic atrophy secondary to dry age-related macular degeneration.
Key inclusion criteria
Patients with geographic atrophy secondary to dry age-related macular degeneration.
Objectives
The objectives of this study are to evaluate the safety and efficacy of subthreshold micropulse laser on the RPE in subjects with GAAMD and to evaluate whether RPE regeneration occurs and progression of atrophy is delayed in the areas treated with subthreshold micropulse laser.
If you are interested in taking part in a clinical trial, please call us at +34 93 595 01 55 and we will assess whether you are eligible.
MicroPulse laserDry or atrophic AMDExudative or wet AMDFluorescein angiographyMicroperimetryAutofluorescenceRetina scanOptical coherence tomographyAuthor
Dr. Jordi Monés, M.D., Ph.D.
COMB Medical license number: 22.838
Director
Doctor of Medicine and Surgery
Specialist in Ophthalmology
Specialist in Retina, Macula and Vitreorretinal
